Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment.
Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L.
G Ital Nefrol. 2022 Jun 20;39(3):2022-vol3.
Renal cell carcinoma.
Rini BI, Campbell SC, Escudier B.
Lancet. 2009 Mar 28;373(9669):1119-32. doi: 10.1016/S0140-6736(09)60229-4. Epub 2009 Mar 5.
Treatment Landscape of Renal Cell Carcinoma.
Chen YW, Wang L, Panian J, Dhanji S, Derweesh I, Rose B, Bagrodia A, McKay RR.
Curr Treat Options Oncol. 2023 Dec;24(12):1889-1916. doi: 10.1007/s11864-023-01161-5. Epub 2023 Dec 28.
Papillary renal cell carcinoma: Review.
Mendhiratta N, Muraki P, Sisk AE Jr, Shuch B.
Urol Oncol. 2021 Jun;39(6):327-337. doi: 10.1016/j.urolonc.2021.04.013. Epub 2021 May 24.
Comprehensive review of chromophobe renal cell carcinoma.
Garje R, Elhag D, Yasin HA, Acharya L, Vaena D, Dahmoush L.
Crit Rev Oncol Hematol. 2021 Apr;160:103287. doi: 10.1016/j.critrevonc.2021.103287. Epub 2021 Mar 19.
Renal Cell Carcinoma of Variant Histology: Biology and Therapies.
Msaouel P, Genovese G, Tannir NM.
Hematol Oncol Clin North Am. 2023 Oct;37(5):977-992. doi: 10.1016/j.hoc.2023.04.019. Epub 2023 May 25.
Metabolic reprogramming in clear cell renal cell carcinoma.
Wettersten HI, Aboud OA, Lara PN Jr, Weiss RH.
Nat Rev Nephrol. 2017 Jul;13(7):410-419. doi: 10.1038/nrneph.2017.59. Epub 2017 May 8.
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
Linehan WM, Ricketts CJ.
Nat Rev Urol. 2019 Sep;16(9):539-552. doi: 10.1038/s41585-019-0211-5. Epub 2019 Jul 5.
Renal cell carcinoma.
Mulders PF.
World J Urol. 2008 Apr;26(2):113. doi: 10.1007/s00345-008-0248-1. Epub 2008 Apr 4.
Papillary Renal Cell Carcinoma (PRCC): An Update.
Akhtar M, Al-Bozom IA, Al Hussain T.
Adv Anat Pathol. 2019 Mar;26(2):124-132. doi: 10.1097/PAP.0000000000000220.
